Pridopidine in Amyotrophic Lateral Sclerosis

Overview of attention for article published in JAMA: Journal of the American Medical Association, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 4 public wall posts from 3 users.

Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week RCT.

Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week RCT. https://ja.ma/4k3t4Ee

From JAMA: Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week RCT. https://ja.ma/3Qku…

From JAMA: Pridopidine did not impact the progression of amyotrophic lateral sclerosis in this 24-week RCT. https://ja.ma/42Ur…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.